Eisai Prepares For Belviq Launch: An Interview With CEO Lonnel Coats
This article was originally published in The Pink Sheet Daily
Executive Summary
Eisai Inc.’s President and CEO Lonnel Coats discussed his approach to the U.S. obesity market and how he plans to position Belviq. The company needs to replace lost revenue from its off-patent blockbuster Aricept but Coats thinks he has the right mix of label, product and experience to win.